EKG vs. BBC
EKG (First Trust Nasdaq Lux Digital Health Solutions ETF) and BBC (Virtus LifeSci Biotech Clinical Trials ETF) are both Health & Biotech Equities funds - EKG tracks the NASDAQ Lux Health Tech Index while BBC tracks the LifeSci Biotechnology Clinical Trials Index. Both are passively managed. Over the past 3 years, EKG returned -0.66%/yr vs 19.99%/yr for BBC. A 0.60 correlation means they provide meaningful diversification when combined. EKG charges 0.65%/yr vs 0.79%/yr for BBC.
Performance
EKG vs. BBC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EKG achieves a -10.11% return, which is significantly lower than BBC's 8.64% return.
EKG
- 1D
- -0.20%
- 1M
- 2.98%
- YTD
- -10.11%
- 6M
- -12.99%
- 1Y
- -0.93%
- 3Y*
- -0.66%
- 5Y*
- —
- 10Y*
- —
BBC
- 1D
- 0.43%
- 1M
- -6.52%
- YTD
- 8.64%
- 6M
- 14.08%
- 1Y
- 116.78%
- 3Y*
- 19.99%
- 5Y*
- -1.96%
- 10Y*
- 7.64%
EKG vs. BBC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
EKG First Trust Nasdaq Lux Digital Health Solutions ETF | -10.11% | 11.89% | 6.53% | -0.11% | -19.59% |
BBC Virtus LifeSci Biotech Clinical Trials ETF | 8.64% | 63.77% | -1.11% | -1.80% | -11.52% |
Correlation
The correlation between EKG and BBC is 0.46, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.46 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.53 |
Correlation (All Time) Calculated using the full available price history since Mar 24, 2022 | 0.60 |
The correlation between EKG and BBC shifts across timeframes, from 0.46 (1 year) to 0.60 (all time), reflecting how their relationship changes across market environments.
EKG vs. BBC - Sectors Allocation Comparison
Sectors
EKG
BBC
Healthcare
Technology
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Utilities
-
-
Healthcare
EKG
BBC
Technology
EKG
BBC
-
Basic Materials
EKG
-
BBC
-
Communication Services
EKG
-
BBC
-
Consumer Cyclical
EKG
-
BBC
-
Consumer Defensive
EKG
-
BBC
-
Energy
EKG
-
BBC
-
Financial Services
EKG
-
BBC
-
Industrials
EKG
-
BBC
-
Real Estate
EKG
-
BBC
-
Utilities
EKG
-
BBC
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EKG vs. BBC — Risk / Return Rank
EKG
BBC
EKG vs. BBC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EKG | BBC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.36 | ||
| Sortino ratioReturn per unit of downside risk | -3.89 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 1.46 | -0.45 |
| Calmar ratioReturn relative to maximum drawdown | -0.04 | 7.78 | -7.82 |
| Martin ratioReturn relative to average drawdown | -0.10 | 24.80 | -24.89 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| EKG | BBC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.04 | 3.32 | -3.36 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.05 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.20 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.13 | 0.12 | -0.25 |
Drawdowns
EKG vs. BBC - Drawdown Comparison
The maximum EKG drawdown since its inception was -43.82%, smaller than the maximum BBC drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for EKG and BBC.
Loading charts...
Drawdown Indicators
| EKG | BBC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -43.82% | -76.85% | +33.03% |
Max Drawdown (1Y)Largest decline over 1 year | -22.09% | -15.10% | -6.99% |
Max Drawdown (3Y)Largest decline over 3 years | -34.49% | -54.45% | +19.96% |
Max Drawdown (5Y)Largest decline over 5 years | — | -72.44% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -76.85% | — |
Current DrawdownCurrent decline from peak | -20.78% | -30.27% | +9.49% |
Average DrawdownAverage peak-to-trough decline | -22.66% | -37.14% | +14.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.73% | 4.73% | +5.00% |
Volatility
EKG vs. BBC - Volatility Comparison
The current volatility for First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) is 7.09%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 10.93%. This indicates that EKG experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EKG | BBC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.09% | 10.93% | -3.84% |
Volatility (6M)Calculated over the trailing 6-month period | 16.42% | 26.43% | -10.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.57% | 35.50% | -13.93% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.07% | 39.31% | -12.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.07% | 37.74% | -10.67% |
EKG vs. BBC - Expense Ratio Comparison
EKG has a 0.65% expense ratio, which is lower than BBC's 0.79% expense ratio.
Dividends
EKG vs. BBC - Dividend Comparison
EKG has not paid dividends to shareholders, while BBC's dividend yield for the trailing twelve months is around 1.56%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.56% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
EKG First Trust Nasdaq Lux Digital Health Solutions ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
EKG and BBC have a correlation of 0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (10.93%) compared to EKG (7.09%). In terms of maximum drawdown, EKG dropped -43.82% vs BBC's -76.85%.
On 3-year performance, BBC leads with 19.99% vs -0.66% for EKG. On fees, EKG is cheaper at 0.65% per year. On volatility, EKG has been the lower-risk option at 7.09%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, BBC has performed better with a 19.99% return vs -0.66%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
EKG is cheaper with a 0.65% expense ratio, compared with 0.79% for BBC.
BBC has the higher dividend yield at 1.56%, compared with 0.00% for EKG.
EKG tracks NASDAQ Lux Health Tech Index, while BBC tracks LifeSci Biotechnology Clinical Trials Index. They also come from different issuers: First Trust and Virtus Investment Partners. Their fees differ too: 0.65% for EKG and 0.79% for BBC.
BBC currently has the higher Sharpe Ratio (3.32 vs -0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EKG and BBC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer